You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Aging Neurosci., 02 August 2023

Sec. Cellular and Molecular Mechanisms of Brain-aging

Volume 15 - 2023 | https://doi.org/10.3389/fnagi.2023.1250440

Corrigendum: CREB5 hypermethylation involved in the ganglioside GM1 therapy of Parkinson's disease

    RW

    Rui Wang 1

    ST

    Shanshan Tong 1

    MW

    Mengdi Wang 1

    JZ

    Junjie Zou 2

    NW

    Nan Wang 3

    FS

    Fengjiao Sun 3

    XZ

    Xiaosheng Zhou 1*

    JC

    Jinbo Chen 1

    HW

    Hongcai Wang 1*

  • 1. Department of Neurology, Binzhou Medical University Hospital, Binzhou, Shandong, China

  • 2. Department of Neurology, Penglai People's Hospital, Yantai, China

  • 3. Medical Research Center, Binzhou Medical University Hospital, Binzhou, Shandong, China

Article metrics

View details

1

Citations

1,4k

Views

686

Downloads

In the published article, there was an error in Figure 5A, Image d as published. We inadvertently used the wrong figure and need to correct the Figure 5A, Image d. The other elements of the Figure 5 remain the same. The corrected Figure 5A, Image d and its caption appear below.

Figure 5

Figure 5

GM1 prevented ROT-induced cell apoptosis. (A, B) Impaired neurite outgrowth was inhibited by GM1 addition. Scale bar = 10 μm. (C, D) GM1 decreased ROT-induced cell apoptosis. *P < 0.05; ****P < 0.0001; #,##P > 0.05.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

monosialotetrahexosylganglioside (GM1), Parkinson's disease (PD), DNA methylation, rotenone (ROT), cell apoptosis

Citation

Wang R, Tong S, Wang M, Zou J, Wang N, Sun F, Zhou X, Chen J and Wang H (2023) Corrigendum: CREB5 hypermethylation involved in the ganglioside GM1 therapy of Parkinson's disease. Front. Aging Neurosci. 15:1250440. doi: 10.3389/fnagi.2023.1250440

Received

30 June 2023

Accepted

24 July 2023

Published

02 August 2023

Volume

15 - 2023

Edited and reviewed by

Jorge Busciglio, University of California, Irvine, United States

Updates

Copyright

*Correspondence: Hongcai Wang Xiaosheng Zhou

†These authors have contributed equally to this work and share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics